These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 17693596

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans.
    Coste A, Turner V, Ischer F, Morschhäuser J, Forche A, Selmecki A, Berman J, Bille J, Sanglard D.
    Genetics; 2006 Apr; 172(4):2139-56. PubMed ID: 16452151
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Distinct roles of Candida albicans drug resistance transcription factors TAC1, MRR1, and UPC2 in virulence.
    Lohberger A, Coste AT, Sanglard D.
    Eukaryot Cell; 2014 Jan; 13(1):127-42. PubMed ID: 24243794
    [Abstract] [Full Text] [Related]

  • 5. Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance in vivo in Candida albicans orchestrated by multiple genetic alterations.
    Jensen RH, Astvad KM, Silva LV, Sanglard D, Jørgensen R, Nielsen KF, Mathiasen EG, Doroudian G, Perlin DS, Arendrup MC.
    J Antimicrob Chemother; 2015 Sep; 70(9):2551-5. PubMed ID: 26017038
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Selected mechanisms of molecular resistance of Candida albicans to azole drugs.
    Gołąbek K, Strzelczyk JK, Owczarek A, Cuber P, Ślemp-Migiel A, Wiczkowski A.
    Acta Biochim Pol; 2015 Sep; 62(2):247-51. PubMed ID: 25901298
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection.
    MacCallum DM, Coste A, Ischer F, Jacobsen MD, Odds FC, Sanglard D.
    Antimicrob Agents Chemother; 2010 Apr; 54(4):1476-83. PubMed ID: 20086148
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reduced susceptibility of Candida albicans clinical isolates to azoles and detection of mutations in the ERG11 gene.
    Zhang L, Yang HF, Liu YY, Xu XH, Ye Y, Li JB.
    Diagn Microbiol Infect Dis; 2013 Dec; 77(4):327-9. PubMed ID: 24070847
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The transcription factor Ndt80 does not contribute to Mrr1-, Tac1-, and Upc2-mediated fluconazole resistance in Candida albicans.
    Sasse C, Schillig R, Dierolf F, Weyler M, Schneider S, Mogavero S, Rogers PD, Morschhäuser J.
    PLoS One; 2011 Dec; 6(9):e25623. PubMed ID: 21980509
    [Abstract] [Full Text] [Related]

  • 17. PAP1 [poly(A) polymerase 1] homozygosity and hyperadenylation are major determinants of increased mRNA stability of CDR1 in azole-resistant clinical isolates of Candida albicans.
    Manoharlal R, Gorantala J, Sharma M, Sanglard D, Prasad R.
    Microbiology (Reading); 2010 Feb; 156(Pt 2):313-326. PubMed ID: 19910410
    [Abstract] [Full Text] [Related]

  • 18. Induction of Candida albicans drug resistance genes by hybrid zinc cluster transcription factors.
    Schneider S, Morschhäuser J.
    Antimicrob Agents Chemother; 2015 Jan; 59(1):558-69. PubMed ID: 25385116
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.